STOCK ALARM
PRO
Continuous market monitoring. Instant alerts.
Subscribe
Sign In
Free Account
Home
Markets
Screener
Movers
Relative Strength
Chart Builder
PODD
NASDAQ
After Hours
Insulet Corporation
$288.73
$2.78 (-0.95%)
As of 10:31 AM
Open
$296.36
High
$299.47
Low
$287.52
Prev Close
$291.51
52W High
$354.88
52W Low
$230.05
Volume
956.69K
Mkt Cap
$20.31B
Overview
News
Chart
Fundamentals
Key Metrics
TTM
Financials
Earnings
Growth
Rating
Analysts
Institutional
Peers
Historical
Analyst Ratings & Price Targets
Recent Analyst Actions
Dec 16, 2025
Evercore ISI
Insulet initiated with an Outperform at Evercore ISI
Target:
$370.00
+25.3%
from $295.31
Nov 24, 2025
Canaccord Genuity
Insulet price target raised to $432 from $428 at Canaccord
Target:
$432.00
+30.4%
from $331.17
Nov 21, 2025
Truist Financial
Insulet price target raised to $412 from $390 at Truist
Target:
$412.00
+26.8%
from $325.00
Nov 21, 2025
RBC Capital
Insulet price target raised to $380 from $370 at RBC Capital
Target:
$380.00
+17.2%
from $324.19
Nov 21, 2025
BTIG
Insulet price target raised to $380 from $370 at BTIG
Target:
$380.00
+21.4%
from $312.89
Nov 19, 2025
UBS
Insulet upgraded to Buy from Neutral at UBS
Target:
$400.00
+20.0%
from $333.47
Nov 6, 2025
Jefferies
Insulet Corporation (PODD) PT Raised to $400 at Jefferies
Target:
$400.00
+23.7%
from $323.40
Nov 6, 2025
BTIG
BTIG Reiterates Buy Rating on Insulet Corporation (PODD)
Target:
$370.00
+14.4%
from $323.40
Nov 5, 2025
Barclays
Insulet price target raised to $301 from $300 at Barclays
Target:
$301.00
-6.0%
from $320.27
Oct 10, 2025
RBC Capital
Insulet price target raised to $365 from $350 at RBC Capital
Target:
$365.00
+14.8%
from $318.00
Sep 29, 2025
Canaccord Genuity
Insulet price target raised to $399 from $353 at Canaccord
Target:
$399.00
+25.5%
from $318.00
Apr 28, 2025
Wells Fargo
Wells Fargo sees new CEO appointment as 'significant positive' for Insulet
Target:
$322.00
+24.1%
from $259.52
Nov 8, 2024
BTIG
Insulet Corporation (PODD) PT Raised to $270 at BTIG
Target:
$270.00
+0.4%
from $268.96
Nov 5, 2024
Bernstein
Bernstein SocGen Group Starts Insulet Corporation (PODD) at Outperform
Target:
$300.00
+24.3%
from $241.32
Oct 14, 2024
Raymond James
Insulet price target raised to $260 from $213 at Raymond James
Target:
$260.00
+12.3%
from $231.61
Sep 17, 2024
Piper Sandler
Insulet price target raised to $285 from $230 at Piper Sandler
Target:
$285.00
+21.9%
from $233.89
Aug 27, 2024
Piper Sandler
Piper Sandler Reiterates Overweight Rating on Insulet Corporation (PODD)
Target:
$230.00
+18.9%
from $193.51
Aug 27, 2024
Oppenheimer
Oppenheimer Reiterates Outperform Rating on Insulet Corporation (PODD)
Target:
$233.00
+20.4%
from $193.54
Aug 27, 2024
Jefferies
Jefferies Reiterates Buy Rating on Insulet Corporation (PODD)
Target:
$260.00
+34.3%
from $193.54
Aug 9, 2024
BTIG
Insulet price target lowered to $250 from $270 at BTIG
Target:
$250.00
+25.1%
from $199.79
May 13, 2024
Barclays
Insulet price target lowered to $200 from $213 at Barclays
Target:
$200.00
+20.6%
from $165.90
May 7, 2024
Wolfe Research
Insulet upgraded to Outperform from Peer Perform at Wolfe Research
Target:
$200.00
+13.4%
from $176.40
Mar 21, 2024
Canaccord Genuity
Canaccord Genuity Likes Insulet Corporation (PODD) Management Appointment
Target:
$226.00
+35.6%
from $166.64
Jan 6, 2023
Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Insulet, Raises Price Target to $320
Target:
$320.00
+8.5%
from $295.00
Nov 3, 2022
Piper Sandler
Insulet upgraded to Overweight from Neutral at Piper Sandler
Target:
$340.00
+33.2%
from $255.35
Oct 17, 2022
Morgan Stanley
Insulet's Omnipod DASH PDMs recall not material to business, Morgan Stanley says
Target:
$273.00
+21.8%
from $224.16
Aug 23, 2022
Raymond James
Insulet (PODD) Stock: $280 Target And Outperform Rating
Target:
$280.00
+7.7%
from $260.03
Mar 3, 2022
Bank of America Securities
Insulet Corporation (PODD) Stock: $300 Price Target And Buy Rating
Target:
$300.00
+13.0%
from $265.39
Feb 2, 2022
UBS
Insulet upgraded to Buy from Neutral at UBS
Target:
$325.00
+28.4%
from $253.19
Jan 31, 2022
Oppenheimer
Insulet upgraded to Outperform from Perform at Oppenheimer
Target:
$275.00
+10.9%
from $248.00
Dec 6, 2021
Canaccord Genuity
Insulet Omnipod 5 delay not a game changer, says Canaccord
Target:
$330.00
+27.3%
from $259.14
Nov 8, 2021
Berenberg Bank
Analysts Offer Insights on Healthcare Companies: Insulet (NASDAQ: PODD) and Apellis Pharmaceuticals (NASDAQ: APLS)
Target:
$295.00
-5.9%
from $313.47
Nov 5, 2021
Citigroup
Insulet price target raised to $350 from $325 at Citi
Target:
$350.00
+13.6%
from $308.00
Oct 12, 2021
Jefferies
Insulet Corporation (PODD) PT Raised to $340 at Jefferies
Target:
$340.00
+14.3%
from $297.51
Jul 21, 2021
Cowen & Co.
Cowen Assumes Insulet Corporation (PODD) at Outperform
Target:
$310.00
+14.2%
from $271.48
May 7, 2021
Thrivent
Insulet Corporation (PODD) PT Lowered to $250 at Piper Sandler
Target:
$250.00
+6.8%
from $234.19
Analyst Consensus
Buy
Based on 20 analysts
Strong Buy
0 (0%)
Buy
18 (90%)
Hold
2 (10%)
Sell
0 (0%)
Strong Sell
0 (0%)
Price Target Forecast
Current Price
$288.73
Potential Upside
+33.13%
Analyst Price Targets
20 analysts
High
$432.00
Consensus
$384.38
Median
$390.00
Low
$301.00
Low: $301.00
High: $432.00
Current price position